Literature DB >> 4125628

Caveat to protein replacement therapy for genetic disease. Immunological implications of accurate molecular diagnosis.

S H Boyer, D C Siggers, L J Krueger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4125628     DOI： 10.1016/s0140-6736(73)92489-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  A serological investigation into the acidic alpha-D-mannosidase in normal Angus cattle and in a calf with mannosidosis.

Authors:  N C Phillips; B G Winchester
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

2.  Immunological evaluation of repeated administration of erythrocyte-entrapped protein to C3H/HeJ mice.

Authors:  M B Fiddler; L D Hudson; R J Desnick
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

3.  Nerve growth factor and some inherited neurological conditions.

Authors:  D C Siggers
Journal:  Proc R Soc Med       Date:  1976-03

4.  Human beta-glucuronidase deficiency mucopolysaccharidosis: identification of cross-reactive antigen in cultured fibroblasts of deficient patients by enzyme immunoassay.

Authors:  C E Bell; W S Sly; F E Brot
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

Review 5.  The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders.

Authors:  A Broomfield; S A Jones; S M Hughes; B W Bigger
Journal:  J Inherit Metab Dis       Date:  2016-02-16       Impact factor: 4.982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.